CVS Offers A Compelling Turnaround Opportunity Not Seen In Years
Source: SeekingAlpha
2026-06-09 23:47:38 ET
CVS Health ( CVS ) spent significant portions of 2024 and 2025 under a microscope as investors eyed whether the company could rebound from a slump. During Q1 2024 , the company reported $400 million in elevated medical cost pressures, primarily driven by increased utilization trends. The company missed analysts' expectations on both revenue and earnings that quarter, and the stock continued to struggle throughout much of 2024 and 2025:
Read the full article on Seeking Alpha
For further details see:
CVS Offers A Compelling Turnaround Opportunity Not Seen In Years
CVS Health Corporation
NASDAQ: CVS
CVS Trading
1.64% G/L:
$105.995 Last:
2,752,121 Volume:
$105 Open:
CVS Latest News
July 08, 2026 10:30:00 am
HIV Is Now a Manageable Chronic Condition - How CVS Specialty Helps Patients Start and Stay on Treatment
July 07, 2026 08:30:00 am
CVS Health: Thank You! Mews at St. Mary Affordable Housing Grand Opening - Williamstown, New Jersey
$95,397,851,248
1,255,468,728
N/A
1076
N/A
Medical Service Plans
Healthcare
US
Woonsocket
